版本:
中国

BRIEF-Myovant Sciences announces presentation of positive Phase 2 data for Relugolix

May 7 Myovant Sciences Ltd:

* Myovant Sciences announces presentation of positive phase 2 data for Relugolix in women with heavy menstrual bleeding and uterine fibroids at the annual meeting of the American Congress of Obstetricians and Gynecologists

* Says study met its primary endpoint Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐